Free Trial

biote (BTMD) Stock Price, News & Analysis

biote logo
$2.88 -0.04 (-1.37%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.91 +0.03 (+0.90%)
As of 08/8/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About biote Stock (NASDAQ:BTMD)

Key Stats

Today's Range
$2.87
$3.04
50-Day Range
$2.88
$4.55
52-Week Range
$2.87
$6.98
Volume
239,176 shs
Average Volume
133,724 shs
Market Capitalization
$157.56 million
P/E Ratio
3.20
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Moderate Buy

Company Overview

biote Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

BTMD MarketRank™: 

biote scored higher than 52% of companies evaluated by MarketBeat, and ranked 442nd out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    biote has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    biote has only been the subject of 1 research reports in the past 90 days.

  • Read more about biote's stock forecast and price target.
  • Earnings Growth

    Earnings for biote are expected to decrease by -28.00% in the coming year, from $0.75 to $0.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of biote is 3.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of biote is 3.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.95.

  • Percentage of Shares Shorted

    2.90% of the float of biote has been sold short.
  • Short Interest Ratio / Days to Cover

    biote has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in biote has recently decreased by 2.23%, indicating that investor sentiment is improving.
  • Dividend Yield

    biote does not currently pay a dividend.

  • Dividend Growth

    biote does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.90% of the float of biote has been sold short.
  • Short Interest Ratio / Days to Cover

    biote has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in biote has recently decreased by 2.23%, indicating that investor sentiment is improving.
  • News Sentiment

    biote has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for biote this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for BTMD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, biote insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    24.00% of the stock of biote is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 21.68% of the stock of biote is held by institutions.

  • Read more about biote's insider trading history.
Receive BTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter.

BTMD Stock News Headlines

B. Riley Issues Negative Estimate for biote Earnings
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
B. Riley Securities Downgrades biote (BTMD)
biote Corp. (BTMD) Q2 2025 Earnings Call Transcript
Biote Reports Second Quarter 2025 Financial Results
Biote Names Rich Barrera to Board of Directors
See More Headlines

BTMD Stock Analysis - Frequently Asked Questions

biote's stock was trading at $6.18 at the beginning of the year. Since then, BTMD shares have decreased by 53.4% and is now trading at $2.88.

biote Corp. (NASDAQ:BTMD) issued its earnings results on Wednesday, August, 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.04. The firm had revenue of $48.86 million for the quarter, compared to analysts' expectations of $49.52 million. biote had a net margin of 15.73% and a negative trailing twelve-month return on equity of 19.71%.
Read the conference call transcript
.

Top institutional shareholders of biote include Acadian Asset Management LLC (1.25%), Geode Capital Management LLC (1.13%), Los Angeles Capital Management LLC (0.37%) and Connor Clark & Lunn Investment Management Ltd. (0.03%). Insiders that own company stock include Guines Llc, Roystone Capital Management Lp, Stephen Mark Cone, Mary Elizabeth Conlon, Robert Charles Peterson and Samar Jagat Kamdar.
View institutional ownership trends
.

Shares of BTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that biote investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Netflix (NFLX).

Company Calendar

Last Earnings
8/06/2025
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BTMD
CIK
1819253
Employees
194
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$4.00
Potential Upside/Downside
+108.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
3.20
Forward P/E Ratio
3.84
P/E Growth
N/A
Net Income
$3.16 million
Net Margins
15.73%
Pretax Margin
10.93%
Return on Equity
-19.71%
Return on Assets
17.83%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.42
Quick Ratio
1.14

Sales & Book Value

Annual Sales
$197.19 million
Price / Sales
0.80
Cash Flow
$0.76 per share
Price / Cash Flow
3.81
Book Value
($2.78) per share
Price / Book
-1.04

Miscellaneous

Outstanding Shares
54,710,000
Free Float
41,580,000
Market Cap
$157.56 million
Optionable
Not Optionable
Beta
1.21
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:BTMD) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners